Clinical Trials Insight: 700051245
Latest Information Update: 20 Nov 2009
At a glance
- Drugs Zucapsaicin (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Winston Laboratories
- 17 Nov 2009 New trial record.
- 17 Nov 2009 According to a Winston Laboratories media release, based on positive results obtained from a phase II trial (see profile 700041823), two pivotal phase III trials, this and another (see profile 700051244) plan to be initiated.